Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|January 15, 2021
Supplements and Featured Publications
- The Impact and Unmet Needs Associated With Dementia- Related Psychosis
The Impact and Unmet Needs Associated with Dementia-Related Psychosis
Advertisement
This publication is sponsored by Acadia Pharmaceuticals, Inc.
This Clinical Brief explores the prevalence and burden associated with dementia-related psychosis, underscoring a critical unmet need for effective therapy.
.
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
DOJ Abandons Olmstead Defense as Texas v Kennedy Advances
2
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
3
Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis
4
FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera
5